Molecular mimicry in the recognition of glycosphingolipids by Galα3Galβ4GlcNAcβ-binding Clostridium difficile toxin A, human natural anti α-galactosyl IgG and the monoclonal antibody Gal-13: Characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor

Glycobiology

Volumn 6, Issue 6, 1996, Pages 599-609

  Teneberg, Susann ^a   Lönnroth, Ivar ^a   Torres López, Javier F ^a,c   Galili, Uri ^b   Halvarsson, Maria Ölwegård ^a   Angström, Jonas ^a   Karlsson, Karl Anders ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c HOSPITAL DE PEDIATRÍA   (Mexico)

Author keywords

Clostridium difficile toxin A; Gal 3Gal 4GlcNAc epitope; Gal 13 monoclonal antibody; Human anti galactosyl IgG; x2 glycosphingolipid

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; GLYCOSPHINGOLIPID; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; BINDING SITE; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; DRUG CROSS REACTIVITY; ERYTHROCYTE; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOCYTOCHEMISTRY; LIPID ANALYSIS; MASS SPECTROMETRY; MOLECULAR MIMICRY; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; RABBIT; THEORY;

ANIMALS; ANTIBODIES, MONOCLONAL; BACTERIAL TOXINS; CARBOHYDRATE SEQUENCE; CHROMATOGRAPHY, THIN LAYER; ENTEROTOXINS; GLYCOCONJUGATES; GLYCOSPHINGOLIPIDS; HUMANS; IMMUNOGLOBULIN G; MASS SPECTROMETRY; MODELS, MOLECULAR; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; RABBITS;

ANIMALIA; CLOSTRIDIUM DIFFICILE; ORYCTOLAGUS CUNICULUS;

EID: 0029854589     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/6.6.599     Document Type: Article

References (45)

1. Aggarwal, B.B., Eessalu, T.E. and Hass, P.E. (1985) Characterization of receptors for human tumor necrosis factor factor and their regulation by γ-interferon. Nature, 318, 665-667.
2. Ångström, J., Teneberg, S. and Karlsson, K.-A. (1994) Delineation and comparison of ganglioside binding epitopes, for the toxins of Vibrio cholerae, Escherichia coli and Clostridium tetani. Evidence for overlapping epitopes. Proc. Natl. Acad. Sci USA. 91, 11859-11863
3. Bartlett, J.G. (1992) Antibiotic-associated diarrhea. Clin. Infect. Dis., 15, 573-581.
4. Bock, K., Breimer, M.E., Brignole, A., Hansson, G.C., Karlsson, K.-A., Larson, G., Leffler, H., Samuelsson, B.E., Strömberg, N., Svanborg-Edén, C. and Thurin, J. (1985) Specificity of binding of a strain of uropathogenic Escherichia coli to Galα1-4Gal-containing glycosphingolipids. J. Biol. Chem., 260, 8545-8551.
5. Breimer, M., Hansson, G.C., Karlsson, K.-A., Larson, G., Leffler, H., Pascher, I., Pimlott, W. and Samuelsson, B.E. (1980) Fingerprinting of lipid-linked oligosaccharides by mass spectrometry. In Quayle, A. (ed.). Advances in Mass Spectrometry, Vol. 8. Heyden & Son. London, pp. 1097-1108.
6. Clark, G.F., Krivan, H.C., Wilkins, T.D. and Smith, D.F. (1987) Toxin A from Clostridium difficile binds to rabbit erythrocyte glycolipids with terminal Galα1-3Galβ1-4GlcNAc sequences. Arch. Biochem. Biophys., 257, 217-229.
7. Falk, K.-E., Karlsson, K.-A. and Samuelsson, B.E. (1979a) Proton nuclear magnetic resonance analysis of anomeric structure of glycolipids. The globoseries (one to five sugars). Arch. Biochem. Biophys., 192, 164-176.
8. Falk, K.-E., Karlsson, K.-A. and Samuelsson, B.E. (1979b) Proton nuclear magnetic resonance analysis of anomeric structure of glycolipids. Blood group ABH-active substances. Arch. Biochem. Biophys., 192, 177-190.
9. Falk, K.-E., Karlsson, K.-A. and Samuelsson, B.E. (1979c) Proton nuclear magnetic resonance analysis of anomeric structure of glycolipids. Lewis-active and Lewis-like substances. Arch. Biochem. Biophys., 192, 191-202.
10. Fiorentini, C. and Thelestam, M. (1991) Clostridium difficile toxin A and its effects on cells. Toxicon, 29, 543-567.
11. Galili, U. (1989) Abnormal expression of α-galactosyl epitopes in man. A trigger for autoimmune processes? Lancer, Aug 12, 358-361.
12. Galili, U., Rachmilewitz, E.A., Peleg, A. and Flechner, I. (1984) A unique natural human IgG antibody with anti-α-galactosyl specificity. J. Exp. Med., 160, 1519-1531.
13. Galili, U., Basbaum, C.D., Shohet, S.B., Buehler, J. and Macher, B.A. (1987a) Identification of erythrocyte Galα1-3Gal glycosphingolipids with a mouse monoclonal antibody. Gal 13. J. Biol. Chem., 262, 4683-4688.
14. Galili, U., Buehler, J., Shohet, S.B. and Macher, B.A. (1987a) The human natural anti-Gal IgG. III. The sublety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies. J. Exp. Med., 165, 693-704
15. Handa, S. (1963) Blood group active glycolipid from human erythrocytes. Jpn. J. Exp. Med., 33, 347-360.
16. Holgersson, J., Strömberg, N. and Breimer, M.E. (1988) Glycolipids of human large intestine: difference in glycolipid expression related to anatomical localization, epithelial/non-epithelial tissue and the ABO. Le and Se phenotypes of the donors. Biochimie, 70, 1565-1574.
17. Holgersson, J., Jovall, P.-Å. and Breimer, M.E. (1991) Glycosphingolipids of human large intestine: detailed structural characterization with special reference to blood group compounds and bacterial receptor structures. J. Biochem., 110, 120-131.
18. Imberty, A., Delage, M.-M., Bourne, Y., Cambillau, C. and Pérez, S. (1991) Data bank of three-dimensional structures of disaccharides. II. N-Acetyllactosaminic N-glycans. Comparison with the crystal structure of a biantennary octasaccharide. Glycoconj. J., 8, 456-483.
19. Joziasse, D.H., Shaper, J.H., Van den Eijnden, D.H., Van Tunen, A.J. and Shaper, N.L. (1989) Bovine α-3galactosyltransferase: isolation and characterization of a cDNA clone. Identification of homologous sequences in human genomic DNA. J. Biol. Chem., 264, 14290-14297.
20. Just, I., Wilm, M., Selzer, J., Rex, G., von Eichel-Streiber, C. Mann, M. and Aktories, K. (1995) The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J. Biol. Chem., 270, 13932-13936.
21. Kannagi, R., Fukuda, M.N. and Hakomori, S.-i. (1982a) A new glycolipid antigen isolated from human erythrocyte membranes reacting with antibodies directed to globo-N-tetraosylceramide (globoside). J. Biol. Chem., 257, 4438-4442.
22. α- first studied in 1951. Cancer Res., 42, 5249-5254.
23. Karlsson, K.-A. (1976) Microscale fingerprinting of blood-group fucolipids by mass specrrometry. In Witting, L.A. (ed), Glycolipid Methodology. American Oil Chemists' Society, Champaign. IL, pp. 97-122.
24. Karlsson, K.-A. (1978) Mass-spectrometric sequence studies of lipid-linked oligosaccharides, blood-group fucolipids, gangliosides and related cell-surface receptors Prog. Chem. Fats Other Lipids. 16, 207-230.
25. Karlsson, K.-A. (1987) Preparation of total non-acid glycolipids for overlay analysis of receptors for bactena and viruses and for other studies. Methods Enzymol., 138, 212-220.
26. Karlsson, K.-A. and Strömberg, N. (1987) Overlay and solid-phase analysis of glycolipid receptors for bacteria and viruses. Methods Enzymol., 138, 220-232.
27. Koerner, T.A.W, Jr., Prestegard, J.H., Demou, P.C. and Yu, R.K. (1983) High-resolution proton NMR studies of gangliosides. 1. Use of homonuclear spin-echo J-correlated spectroscopy for determination of residue composition and anomeric configurations. Biochemistry, 22, 2676-2687.
28. Krivan, H.C., Clark, G.F., Smith, D.F. and Wilkins, T.D. (1986) Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Galα1-3Galβ1-4GlcNAc. Infect. Immun., 53, 573-581.
29. Larsen, R.D., Rivera-Marrero, C.A., Ernst, L.K., Cummings, R.D. and Lowe, J.B. (1990) Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:β-D-Gal(1, 4)-D-GlcNAcα(1, 3)-galactosyltransferase cDNA. J. Biol Chem., 265, 7055-7061.
30. Larson, G., Karlsson, H., Hansson, G.C. and Pimlott, W. (1987) Application of a simple methylation procedure for the analysis of glycosphingolipids. Carbohydr. Res., 161, 281-290.
31. 125I-labelled toxin to thin-layer chromatograms Anal. Biochem., 109, 399-402.
32. Magnani, J.L., Brockhaus, M., Smith, D.F., Ginsburg, V., Blaszczyk, M., Mitchell, K.F., Steplewski, Z. and Koprowski, H. (1981) A monosialoganglioside is a monoclonal antibody-defined antigen of colon-carcinoma. Science, 212, 55-56.
33. Mayo, S.M., Olafson, B.D. and Goddard, W.A., II (1990) Dreiding: a generic force field for molecular simulations. J. Phys Chem., 94, 8897-8909.
34. Rappé, A.K. and Goddard, W.A., II (1991) Charge equilibration for molecular dynamics simulations. J. Phys. Chem., 95, 3358-3363.
35. Samuelsson, B.E., Pimlott, W. and Karlsson, K.-A. (1990) Mass spectrometry of mixtures of intact glycosphingolipids. Methods Enzymol., 193, 623-646.
36. Stellner, K. and Hakomori, S.-i. (1974) A ceramide pentasaccharide of human erythrocyte membrane. J. Biol Chem., 249, 1022-1025.
37. Stellner, J.C., Saito, H. and Hakomori, S.-i. (1973) Determination of aminosugar linkages in glycolipids by methylation. Aminosugar linkages of ceramide pentasaccharides of rabbit erythrocytes and of Forssman antigen. Arch. Biochem. Biophys., 155, 464-472.
38. 2 glycosphingolipid, its extended form, and its sialosyl derivatives: accumulation associated with the rare blood group p phenotype. Biochemistiy, 31, 6509-6517.
39. Torres, J.F. and Lonnroth, I. (1988) Comparison of methods for the production and purification of toxin A from Clostridium difficile. FEMS Microbiol. Lett., 52, 41-16.
40. Torres, J.F. and Lönnroth, I. (1989) Production, purification and characterization of Clostridium difficile toxic proteins different from toxin A and from toxin B. Biochim. Biophys. Acta. 998, 151-157.
41. Tucker, K.D. and Wilkins, T.D. (1991 ) Toxin A of Clostridium difficile binds to the human carbohydrate antigens I. X. and Y. Infect. Immun., 59, 73-78.
42. Waldi, D. (1962) Sprühreagentien fur die dünnschicht-chromatographie. In Stahl.E. (ed), Dunnschicht-Chromatographie. Springer-Verlag, Berlin, pp. 496-515.
43. von Eichel-Streiber, C., Sauerborn, M. and Kuramitsu, H.K. (1992) Evidence for a molecular structure of homologous repetitive C-terminal carbohydrate-binding sites of Clostridium difficile toxins and Streptococcus mutans glucosyltransferases. J. Bacteriol., 174, 6707-6710.
44. Wolfhagen, M.J.H.M., Toresma, R., Fluit, A.C. and Verhoef, J. (1994) Toxins A and B of Clostridium difficile. FEMS Microbiol. Rev., 13, 59-64.
45. Yang, H.-J. and Hakomori, S.-i. (1971) A sphingolipid having a novel ceramide and lacto-N-fucopentose III. J. Biol. Chem., 246, 1192-1200.